Hong Kong Seeks to Cash In on Frenzy For Chinese Biotech Stocks – Bloomberg

Bloomberg
Annual spending on prescription medicines has crossed $100 billion in China as the incidences of diseases like diabetes and cancer have surged. The Asian country has lagged behind the U.S. and other developed markets on innovation, and Beijing has said

…read more

Source:: Hong Kong News By Google News

Leave a Comment